fashion -WSS

fashion

author：hotspot 2025-10-01 17:20:44 - browse：9

Ford F-150 Recall — FILE - A 2021 F-150 pickup truck at a Ford dealer in southeast Denver, Oct. 24, 2021. Ford is recalling more than 870,000 newer F-150 pickup trucks in the U.S. because the electric parking brakes can turn on unexpectedly. The recall covers certain pickups from the 2021 through 2023 model years with single exhaust systems. Ford's F-Series pickups are the top-selling vehicles in the U.S. (AP Photo/David Zalubowski, File)The Associated Press

DEARBORN, Mich. -- Ford is recalling more than 870,000 newer F-150 pickup trucks in the U.S. because the electric parking brakes can turn on unexpectedly.

The recall covers certain pickups from the 2021 through 2023 model years with single exhaust systems. Ford's F-Series pickups are the top-selling vehicles in the U.S.

The company says in documents posted by government safety regulators Friday that a rear wiring bundle can come in contact with the rear axle housing. That can chafe the wiring and cause a short circuit, which can turn on the parking brake without action from the driver, increasing the risk of a crash.

Drivers may see a parking brake warning light and a warning message on the dashboard.

Ford says in documents that it has 918 warranty claims and three field reports of wire chafing in North America. Of these, 299 indicated unexpected parking brake activation, and 19 of these happened while the trucks were being driven.

The company says it doesn't know of any crashes or injuries caused by the problem.

Dealers will inspect the rear wiring harness. If protective tape is worn through, the harness will be replaced. If the tape isn't worn, dealers will install a protective tie strap and tape wrap.

Owners will be notified by letter starting Sept. 11.

Owners with questions can call Ford customer service at (866) 436-7332.

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

WSS

A single Democrat is willing to weaken Medicare negotiation power

Washington mulls new rules to avert another Change Healthcare

Patient advocates debate FDA's accelerated approval process

The Biogen Aduhelm mess could happen again

Unique patient identifier: Experts argue the benefits, pitfalls

A protest over insulin prices is seen as a fight for life

explore

fashion

focus

Apple is now the first public company to be valued at $3 trillion

Decaf coffee targeted by food safety group under obscure FDA rule

Novavax promises a turnaround & Lilly roils the obesity market

Bernie brings in new pharma CEOs to talk drug prices

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Trump demands the U.S. pay no more for drugs than other countries … again

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

At least 13 dead in Texas as scorching temps continue

The Readout: Lenmeldy, GLP

focus

Texas Medical Board asked to define abortion emergency exception

A protest over insulin prices is seen as a fight for life

Abortion pill case raises question: who can sue the FDA?

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

A protest over insulin prices is seen as a fight for life

A single Democrat is willing to weaken Medicare negotiation power

explore

entertainment

Wikipedia

leisure time